Literature DB >> 9292145

Functional and clinical aspects of the myelomonocyte protein calprotectin.

B Johne1, M K Fagerhol, T Lyberg, H Prydz, P Brandtzaeg, C F Naess-Andresen, I Dale.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9292145      PMCID： PMC379605          DOI： 10.1136/mp.50.3.113

Source DB:  PubMed          Journal:  Mol Pathol        ISSN： 1366-8714


× No keyword cloud information.
  123 in total

1.  The distribution of the antimicrobial protein, calprotectin, in normal oral keratinocytes.

Authors:  L R Eversole; K T Miyasaki; R E Christensen
Journal:  Arch Oral Biol       Date:  1992-11       Impact factor: 2.633

2.  Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin.

Authors:  I Dale; P Brandtzaeg; M K Fagerhol; H Scott
Journal:  Am J Clin Pathol       Date:  1985-07       Impact factor: 2.493

3.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

Authors:  M Steinbakk; C F Naess-Andresen; E Lingaas; I Dale; P Brandtzaeg; M K Fagerhol
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

4.  Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs.

Authors:  T R Meling; L Aabakken; A Røseth; M Osnes
Journal:  Scand J Gastroenterol       Date:  1996-04       Impact factor: 2.423

5.  Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease.

Authors:  N Lügering; R Stoll; T Kucharzik; K W Schmid; G Rohlmann; G Burmeister; C Sorg; W Domschke
Journal:  Digestion       Date:  1995       Impact factor: 3.216

6.  Tissue localization and chromosomal assignment of a serum protein that tracks the cystic fibrosis gene.

Authors:  V van Heyningen; C Hayward; J Fletcher; C McAuley
Journal:  Nature       Date:  1985 Jun 6-12       Impact factor: 49.962

7.  Primary structure and binding properties of calgranulin C, a novel S100-like calcium-binding protein from pig granulocytes.

Authors:  E C Dell'Angelica; C H Schleicher; J A Santomé
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

8.  Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis.

Authors:  J G Brun; E Ulvestad; M K Fagerhol; R Jonsson
Journal:  Scand J Immunol       Date:  1994-12       Impact factor: 3.487

9.  Relationship of neutrophil cytoplasmic protein (L1) to acute and chronic lung disease.

Authors:  R A Stockley; I Dale; S L Hill; M K Fagerhol
Journal:  Scand J Clin Lab Invest       Date:  1984-11       Impact factor: 1.713

10.  Calprotectin levels in oral fluids: the importance of collection site.

Authors:  M Cuida; J G Brun; T Tynning; R Jonsson
Journal:  Eur J Oral Sci       Date:  1995-02       Impact factor: 2.612
View more
  111 in total

1.  Faecal calprotectin levels differentiate intestinal from pulmonary tuberculosis: An observational study from Southern India.

Authors:  Geir Larsson; Koticherry Thrivikrama Shenoy; Ramalingom Ramasubramanian; Lakshmikanthan Thayumanavan; Leena Kondarappassery Balakumaran; Gunnar A Bjune; Bjørn A Moum
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

2.  Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis.

Authors:  Tarang Taghvaei; Iradj Maleki; Farshad Nagshvar; Hafez Fakheri; Vahid Hosseini; Seyed Mohammad Valizadeh; Hassan Neishaboori
Journal:  Intern Emerg Med       Date:  2014-11-04       Impact factor: 3.397

3.  Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.

Authors:  Takayuki Yamamoto; Manabu Shiraki; Takuya Bamba; Satoru Umegae; Koichi Matsumoto
Journal:  Int J Colorectal Dis       Date:  2013-12-17       Impact factor: 2.571

4.  The human innate immune protein calprotectin induces iron starvation responses in Pseudomonas aeruginosa.

Authors:  Emily M Zygiel; Cassandra E Nelson; Luke K Brewer; Amanda G Oglesby-Sherrouse; Elizabeth M Nolan
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

5.  Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.

Authors:  Jana Hurnakova; Hana Hulejova; Jakub Zavada; Martin Komarc; Lucie Andres Cerezo; Herman Mann; Jiri Vencovsky; Karel Pavelka; Ladislav Senolt
Journal:  Clin Rheumatol       Date:  2018-04-14       Impact factor: 2.980

Review 6.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

7.  Human calprotectin affects the redox speciation of iron.

Authors:  Toshiki G Nakashige; Elizabeth M Nolan
Journal:  Metallomics       Date:  2017-08-16       Impact factor: 4.526

8.  Calprotectin as a diagnostic tool for inflammatory bowel diseases.

Authors:  Marianthi Chatzikonstantinou; Panagiotis Konstantopoulos; Spyros Stergiopoulos; Konstantinos Kontzoglou; Christos Verikokos; Despina Perrea; Dimitris Dimitroulis
Journal:  Biomed Rep       Date:  2016-09-07

9.  Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.

Authors:  Michael Wagner; Christer G B Peterson; Peter Ridefelt; Per Sangfelt; Marie Carlson
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 10.  Physical activity before and after diagnosis of colorectal cancer: disease risk, clinical outcomes, response pathways and biomarkers.

Authors:  David J Harriss; N Tim Cable; Keith George; Thomas Reilly; Andrew G Renehan; Najib Haboubi
Journal:  Sports Med       Date:  2007       Impact factor: 11.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.